Histone deacetylase (HDAC) inhibitors represent a class of cytostatic compounds that suppress tumor cell proliferation across diverse experimental models. Their antitumor activity is mediated through the induction of cell cycle arrest, differentiation, or programmed cell death (apoptosis).
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
